The gastric pacemaker manages to reduce a 45% of excess weight after 12 months of treatment.

Madrid, April of 2013.Just a year and a half since they started to settle in Spain first gastric pacemaker, this new system has become the optimal choice for many obese patients seeking a surgical approach to combat the problem. The character minimally invasive of the pacemaker abiliti has become to this system the ideal alternative for patients with obesity who fear more aggressive, as the bypass or gastrectomy tubular surgical modalities, and who are aware about the need to change your eating habits.

In particular, after a median follow-up one year, patients with abiliti have managed to average 45% of its weight to lose excess, according to the results obtained during this time by the medical team that performed the follow-up of these patients in the Clinica La Luz, centro pioneer in Spain in the implantation of this device.

In any case, patients who have obtained a greater benefit are those who had a body mass index (BMI, variable which is calculated by dividing the weight of a person by their height in meters squared) between 30 and 40, who have lost the 53,91% excess weight. However, among patients with higher rates of obesity (BMI greater than 44) weight loss has been, on average, 36% of excess weight, according to data presented recently in Madrid in the I medical-surgical obesity Congress by Dr. Manuel Miras, head of unit of surgery laparoscopic obesity morbid in the light’s

Control Remote

abiliti system operates generating mild electrical stimulation in the stomach through a small electrode, stimuli that provoke feeling of fullness when the person tries to eat or drink outside the specified hours, which allows not only control a distance (via the Internet) by the specialist, but also the re-education from the patient so you get healthier eating habits and eat less food.

Little aggressiveness of the intervention necessary to implant electrode is perfectly illustrated by the time of surgery of the 22 patients who have taken the device between 12 and 24 months. According to the data presented by Dr. Manuel Miras, the average duration of surgery was 53 minutes, with a time of less than 24 hours hospital stay.

doctor Manuel Miras, responsible for the unit of surgery laparoscopic of obesity of the clinic La light.

Average abiliti patients return to their daily lives to 48 hours after the implantation of the device. In addition, in only six hours they can drink, at 12 eating crushed and in just 24 hours may return to eating solid foods. There have been no postoperative adverse effects. Only one of the patients asked to lower the intensity of electrical stimulation and another device was removed at his own request, operation that neither is of any severity and is carried out in a short space of time in if necessary.

According to available data, the greatest weight losses occurred in two patients with a BMI of 30 and 36, which lost respectively 87% and 71% of excess weight. In extreme contrast with the device that has lost less weight is a patient with BMI 42 that has lost 27% of excess weight.

Improve the relationship with food

In addition, according to the results of the TFQ (Three Factor Eating Questionnaire), a psychological tool used to explore eating behavior that measures the aspects that lead a person to gain weight, patients with abiliti ® improve much in their relationship with food: know how much to grow what they eat and already not soothe their anxiety with food.

One of the big advantages is abiliti is that its implementation is minimally invasive as compared to other Bariatric procedures, as highlights the shortsighted doctor. The implant abiliti ® offers numerous advantages: also performed surgery minimally invasive, involving only one day’s stay in the clinic, is not altered in any way neither the anatomy and physiology of the stomach, so the patient does not change their habits of life ”.

According to this specialist, the device can remain implanted all the time that is necessary, since it can be activated and deactivated depending on the needs of the patient. In addition, if necessary, for any reason, remove the device, is perfectly feasible to do so through a simple procedure without complications.

But the use of abiliti has other advantages that are not limited to weight loss. Thus, for patients with metabolic type, such as the diabetes associated diseases, the system allows a narrow figures of blood glucose monitoring.